{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:37:52Z","timestamp":1786995472820,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.path.2020.04.002","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T16:31:33Z","timestamp":1596731493000},"page":"377-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms"],"prefix":"10.1016","volume":"13","author":[{"given":"Raul S.","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2020.04.002_bib1","series-title":"AJCC cancer staging manual","year":"2017"},{"key":"10.1016\/j.path.2020.04.002_bib2","series-title":"WHO classification of tumours: digestive system tumours","first-page":"16","article-title":"Classification of neuroendocrine neoplasms of the digestive system","author":"Klimstra","year":"2019"},{"issue":"12","key":"10.1016\/j.path.2020.04.002_bib3","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","article-title":"A\u00a0common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.04.002_bib4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/annonc\/mds276","article-title":"Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study","volume":"24","author":"Sorbye","year":"2013","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.path.2020.04.002_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/ERC-15-0119","article-title":"Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms","volume":"22","author":"Heetfeld","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.path.2020.04.002_bib6","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1158\/1078-0432.CCR-15-0548","article-title":"Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from poorly differentiated neuroendocrine carcinomas","volume":"22","author":"Tang","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.path.2020.04.002_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00428-017-2258-0","article-title":"Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms","volume":"472","author":"Kl\u00f6ppel","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.path.2020.04.002_bib8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/modpathol.2014.156","article-title":"Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies","volume":"28","author":"Reid","year":"2015","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.path.2020.04.002_bib9","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/bjc.2013.156","article-title":"A\u00a0comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms","volume":"108","author":"Khan","year":"2013","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.path.2020.04.002_bib10","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/PAS.0000000000000662","article-title":"A\u00a0practical approach to the classification of WHO grade 3 (G3) well-differentiated neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of the pancreas","volume":"40","author":"Tang","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2020.04.002_bib11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12022-016-9432-9","article-title":"Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs): unifying the concept of a heterogeneous group of neoplasms","volume":"27","author":"La Rosa","year":"2016","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.path.2020.04.002_bib12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000475527","article-title":"Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms","volume":"105","author":"de Mestier","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"10","key":"10.1016\/j.path.2020.04.002_bib13","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.path.2020.04.002_bib14","doi-asserted-by":"crossref","first-page":"R315","DOI":"10.1530\/ERC-17-0012","article-title":"Genetic and epigenetic drivers of neuroendocrine tumours (NET)","volume":"24","author":"Di Domenico","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.path.2020.04.002_bib15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/PAS.0b013e318159371c","article-title":"Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?","volume":"32","author":"Shia","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2020.04.002_bib16","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.6004\/jnccn.2018.7043","article-title":"Targeting BRAF mutations in high-grade neuroendocrine carcinoma of the colon","volume":"16","author":"Burkart","year":"2018","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.path.2020.04.002_bib17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jso.24834","article-title":"Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma","volume":"117","author":"Idrees","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.path.2020.04.002_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/ERC-14-0410","article-title":"Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity","volume":"22","author":"Sahnane","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.path.2020.04.002_bib19","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/MPA.0b013e3181ebb56f","article-title":"The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas","volume":"39","author":"Strosberg","year":"2010","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.path.2020.04.002_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000487237","article-title":"Clinical and biomarker evaluations of sunitinib in patients with grade 3 digestive neuroendocrine neoplasms","volume":"107","author":"Pellat","year":"2018","journal-title":"Neuroendocrinology"},{"issue":"5","key":"10.1016\/j.path.2020.04.002_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000488996","article-title":"Immune checkpoint inhibitors in the treatment of patients with neuroendocrine neoplasia","volume":"41","author":"Weber","year":"2018","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.path.2020.04.002_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.humpath.2017.10.003","article-title":"Expression of PD-1 and PD-L1 in poorly differentiated neuroendocrine carcinomas of the digestive system: a potential target for anti-PD-1\/PD-L1 therapy","volume":"70","author":"Roberts","year":"2017","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.path.2020.04.002_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00000478-200204000-00016","article-title":"Carcinoid tumor of the esophagus: a clinicopathologic study of four cases","volume":"26","author":"Hoang","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.path.2020.04.002_bib24","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.humpath.2011.01.018","article-title":"Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms","volume":"42","author":"La Rosa","year":"2011","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.path.2020.04.002_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000443168","article-title":"ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms","volume":"103","author":"Delle Fave","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.path.2020.04.002_bib26","author":"Shi"},{"issue":"4","key":"10.1016\/j.path.2020.04.002_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000199786","article-title":"Histopathological classification of nonantral gastric endocrine growths in man","volume":"41","author":"Solcia","year":"1988","journal-title":"Digestion"},{"issue":"1","key":"10.1016\/j.path.2020.04.002_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/his.13367","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: selected pathology review and molecular updates","volume":"72","author":"Chai","year":"2018","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.path.2020.04.002_bib29","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.pas.0000163363.86099.9f","article-title":"Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids: a new disorder","volume":"29","author":"Abraham","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.04.002_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1677\/ERC-07-0157","article-title":"Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity","volume":"15","author":"Garbrecht","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.path.2020.04.002_bib31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000444803","article-title":"Four neuroendocrine tumor types and neuroendocrine carcinoma of the duodenum: analysis of 203 cases","volume":"104","author":"Vanoli","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.path.2020.04.002_bib32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2407-11-187","article-title":"Literature survey on epidemiology and pathology of gangliocytic paraganglioma","volume":"11","author":"Okubo","year":"2011","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.path.2020.04.002_bib33","doi-asserted-by":"crossref","first-page":"L13","DOI":"10.1530\/ERC-16-0148","article-title":"HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma","volume":"23","author":"Zhuang","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"10.1016\/j.path.2020.04.002_bib34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/PAS.0b013e3181655811","article-title":"Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor","volume":"32","author":"Anlauf","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.04.002_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","article-title":"Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years","volume":"249","author":"Bilimoria","year":"2009","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.path.2020.04.002_bib36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/arpa.2015-0105-OA","article-title":"Jejunoileal neuroendocrine tumors complicated by intestinal ischemic necrosis are associated with worse overall survival","volume":"140","author":"Landau","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.path.2020.04.002_bib37","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00000478-200306000-00013","article-title":"Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases","volume":"27","author":"Yantiss","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2020.04.002_bib38","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/his.13771","article-title":"Should Ki67 immunohistochemistry be performed on all lesions in multifocal small intestinal neuroendocrine tumours?","volume":"74","author":"Numbere","year":"2019","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.path.2020.04.002_bib39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1200\/JCO.2012.44.5924","article-title":"Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors","volume":"31","author":"Strosberg","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.path.2020.04.002_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/PAS.0000000000000968","article-title":"The influence of tumor stage on the prognostic value of Ki-67 index and mitotic count in small intestinal neuroendocrine tumors","volume":"42","author":"Sun","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2020.04.002_bib41","series-title":"WHO classification of tumours: digestive system tumours","first-page":"263","article-title":"Hepatic neuroendocrine neoplasms","author":"Klimstra","year":"2019"},{"issue":"9","key":"10.1016\/j.path.2020.04.002_bib42","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/modpathol.2013.232","article-title":"Should mesenteric tumor deposits be included in staging of well-differentiated small intestine neuroendocrine tumors?","volume":"27","author":"Gonzalez","year":"2014","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.04.002_bib43","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/PAS.0000000000000751","article-title":"Mesenteric tumor deposits in midgut small intestinal neuroendocrine tumors are a stronger indicator than lymph node metastasis for liver metastasis and poor prognosis","volume":"41","author":"Fata","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2020.04.002_bib44","series-title":"AJCC cancer staging manual","first-page":"375","article-title":"Neuroendocrine tumors of the jejunum and ileum","author":"Woltering","year":"2017"},{"issue":"10","key":"10.1016\/j.path.2020.04.002_bib45","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41379-018-0075-x","article-title":"Number, not size, of mesenteric tumor deposits affects prognosis of small intestinal well-differentiated neuroendocrine tumors","volume":"31","author":"Gonzalez","year":"2018","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2020.04.002_bib46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jamasurg.2018.3865","article-title":"Prognostic role of lymph node positivity and number of lymph nodes needed for accurately staging small-bowel neuroendocrine tumors","volume":"154","author":"Zaidi","year":"2019","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.path.2020.04.002_bib47","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/PAS.0000000000001225","article-title":"Impact of peritoneal metastasis on survival of patients with small intestinal neuroendocrine tumor","volume":"43","author":"Wright","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.04.002_bib48","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/1078-0432.CCR-15-0373","article-title":"Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor","volume":"22","author":"Karpathakis","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.path.2020.04.002_bib49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.hpb.2017.08.039","article-title":"Cytoreductive debulking surgery among patients with neuroendocrine liver metastasis: a multi-institutional analysis","volume":"20","author":"Ejaz","year":"2018","journal-title":"HPB (Oxford)"},{"issue":"3","key":"10.1016\/j.path.2020.04.002_bib50","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1309\/AJCPQ55SKOCYFZHN","article-title":"Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors","volume":"143","author":"Shi","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.path.2020.04.002_bib51","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0000000000000850","article-title":"The North American neuroendocrine tumor society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors","volume":"46","author":"Strosberg","year":"2017","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.path.2020.04.002_bib52","first-page":"47","article-title":"Peptide receptor radionuclide therapy: an overview","volume":"30","author":"Dash","year":"2015","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"10.1016\/j.path.2020.04.002_bib53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.path.2020.04.002_bib54","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/SLA.0000000000002939","article-title":"Morphological factors related to nodal metastases in neuroendocrine tumors of the appendix: a multicentric retrospective study","volume":"271","author":"Brighi","year":"2020","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.path.2020.04.002_bib55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jso.21764","article-title":"Appendiceal carcinoid tumors: predictors of lymph node metastasis and the impact of right hemicolectomy on survival","volume":"103","author":"Groth","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"issue":"59","key":"10.1016\/j.path.2020.04.002_bib56","doi-asserted-by":"crossref","first-page":"99541","DOI":"10.18632\/oncotarget.20362","article-title":"Regional lymph node involvement and outcomes in appendiceal neuroendocrine tumors: a SEER database analysis","volume":"8","author":"Mehrvarz Sarshekeh","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.path.2020.04.002_bib57","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/PAS.0b013e318275d1d7","article-title":"Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases","volume":"37","author":"Volante","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2020.04.002_bib58","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1066896919845048","article-title":"A\u00a0multifocal pattern of neuroendocrine neoplasms along the appendix: a series of six cases","volume":"27","author":"Mahajan","year":"2019","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2020.04.002_bib59","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00428-018-2407-0","article-title":"Incidentally detected pancreatic neuroendocrine microadenoma with lymph node metastasis","volume":"473","author":"Kwon","year":"2018","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.path.2020.04.002_bib60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.semdp.2004.11.004","article-title":"Neuroendocrine tumors of the\u00a0appendix","volume":"21","author":"Carr","year":"2004","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.path.2020.04.002_bib61","series-title":"WHO classification of tumours: digestive system tumours","first-page":"149","article-title":"Appendiceal goblet cell adenocarcinoma","author":"Misdraji","year":"2019"},{"issue":"2","key":"10.1016\/j.path.2020.04.002_bib62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000443166","article-title":"ENETS consensus guidelines update for colorectal neuroendocrine neoplasms","volume":"103","author":"Ramage","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.path.2020.04.002_bib63","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/his.13769","article-title":"Neuroendocrine proliferations in inflammatory bowel disease: differentiating neuroendocrine tumours from neuroendocrine cell micronests","volume":"74","author":"Wong","year":"2019","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.path.2020.04.002_bib64","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/PAS.0b013e318236e4d2","article-title":"Composite intestinal adenoma-microcarcinoid","volume":"36","author":"Lin","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.04.002_bib65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/cancers4010011","article-title":"Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal tract: an update","volume":"4","author":"La Rosa","year":"2012","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.path.2020.04.002_bib66","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/PAS.0000000000001123","article-title":"Mixed adenoma well-differentiated neuroendocrine tumor (MANET) of the digestive system: an indolent subtype of mixed neuroendocrine-nonneuroendocrine neoplasm (MiNEN)","volume":"42","author":"La Rosa","year":"2018","journal-title":"Am J Surg Pathol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187591812030026X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187591812030026X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:39:52Z","timestamp":1761748792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187591812030026X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S187591812030026X"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2020.04.002","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2020.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}